DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» TYRO3
TYRO3
Failures in Preclinical and Clinical Trials of C-Met Inhibitors: Evaluation of Pathway Activity As a Promising Selection Criterion
Supplementary Table 1. in Vitro Side Effect Profiling Study for LDN/OSU-0212320. Neurotransmitter Related Steroids
The Role of C-Abl Kinase in HCC Development
Dual Targeting of TAM Receptors Tyro3, Axl, and Mertk: Role in Tumors and the Tumor Immune Microenvironment Kai‑Hung Wanga, Dah‑Ching Dingb*
Genome-Wide Screen of Gamma-Secretase–Mediated Intramembrane Cleavage of Receptor Tyrosine Kinases
The Neuregulin Growth Factors and Their Receptor Erbb4 in the Developing Brain: Delineation of Neuregulin-3 Expression and Neuritogenesis Adviser: Anne L
Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients Undergoing Nephrectomy for Locally Advanced Clear Cell Renal Cell Carcinoma Jose A
Role of Vegfs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models
The Emerging Role of TYRO3 As a Therapeutic Target in Cancer
PRODUCTS and SERVICES Target List
TYRO3, Active Recombinant Human Protein Expressed in Sf9 Cells
Supplementary Table S1. Kinase Selectivity of MPI-0479605. (A)
Targeting the Hsp90-Cdc37-Client Protein Interaction to Disrupt Hsp90 Chaperone Machinery Ting Li1, Hu-Lin Jiang2, Yun-Guang Tong3,4 and Jin-Jian Lu1*
Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer
Original Article a RTK-Based Functional Rnai Screen Reveals Determinants of PTX-3 Expression
TYRO3 As a Molecular Target for Growth Inhibition and Apoptosis Induction in Bladder Cancer
Tyrosine Kinase Panel
Top View
Kinome Expression Profiling to Target New Therapeutic Avenues in Multiple Myeloma
Sperm Proteasome Degrades Egg Envelope Glycoprotein ZP1 During
Preclinical Validation of AXL Receptor As a Target for Antibody-Based Pancreatic Cancer Immunotherapy
Targeting Tyro3, Axl and Mertk (TAM Receptors): Implications for Macrophages in the Tumor Microenvironment Kayla V
Tyro3, Axl, and Mertk Receptors Differentially Participate in Platelet
Signaling Networks Assembled by Oncogenic EGFR and C-Met
Identification of New Kinase Clusters Required for Neurite Outgrowth And
Oncogenic Kinase–Induced PKM2 Tyrosine 105 Phosphorylation
Cross-Talk Between Receptor Tyrosine Kinases AXL and ERBB3
BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells S
(12) Patent Application Publication (10) Pub. No.: US 2011/0008347 A1 Ullrich Et Al
AXL Confers Cell Migration and Invasion by Hijacking a PEAK1-Regulated Focal Adhesion Protein Network
The Role of the Receptor Tyrosine Kinase Axl in Carcinogenesis and Development of Therapeutic Resistance: an Overview of Molecular Mechanisms and Future Applications
The Proto-Oncogene C-Kit Inhibits Tumor Growth by Behaving As a Dependence Receptor Hong Wang
Mechanisms of Resistance to T-Dm1 in Her2-Positive Breast Cancer
Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells
Kinome Profiling of Non-Hodgkin Lymphoma Identifies Tyro3 As a Therapeutic Target in Primary Effusion Lymphoma
Autocrine Signaling by Receptor Tyrosine Kinases in Urothelial Carcinoma of the Bladder